Abstract
since covid 19 is associated to a high incidence of thrombo-embolic events, there has been a surge in anticoagulation use for the management of hospitalized covid 19 patients. Yet, anticoagulation is not without risk. Serious hemorrhagic complications may occur and may be fatal. Consequently rapid diagnosis and prompt intervention are essential to ensure good patient outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
